A Study to Characterize Profile of Participant With Psoriatic Arthritis Depending on Whether Their Disease is Managed by a Dermatologist or by a Rheumatologist, and Starting Ustekinumab
Clinical trial NCT03336281 · COMPLETED
Trial details
- NCT number
- NCT03336281
- Sponsor
- Janssen Cilag S.A.S.
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2017-04-25
- Primary completion
- 2020-04-07
- Enrollment
- 221
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.